2
Clinical Trials associated with H7N9 Influenza Vaccine (Split Virion),Inactivated(Hualan Biological Bacterin) / Active, not recruitingPhase 2 评价H7N9流感病毒裂解疫苗在健康人群中接种的安全性和免疫原性的随机、盲法、平行对照II期临床试验
[Translation] A randomized, blinded, parallel controlled phase II clinical trial to evaluate the safety and immunogenicity of H7N9 influenza virus split vaccine in healthy people
进一步考察和评价30μg/剂H7N9流感病毒裂解疫苗在3岁及以上健康人群中按照相应程序接种的免疫原性、安全性、免疫持久性和长期安全性。
[Translation] To further investigate and evaluate the immunogenicity, safety, immune persistence and long-term safety of 30 μg/dose H7N9 influenza virus split vaccine administered according to the corresponding procedures in healthy people aged 3 years and above.
评价H7N9流感病毒疫苗在健康人群中接种的安全性和免疫原性的随机、盲法、安慰剂平行对照Ⅰ期临床试验
[Translation] A randomized, blinded, placebo-controlled phase I clinical trial to evaluate the safety and immunogenicity of H7N9 influenza virus vaccine in healthy people
初步评价华兰生物研发的不同种类、剂量H7N9流感病毒疫苗在相应年龄健康人群中的安全性和免疫原性,为后续试验的进行做数据支持。
[Translation] To preliminarily evaluate the safety and immunogenicity of different types and doses of H7N9 influenza virus vaccines developed by Hualan Biotechnology in healthy people of corresponding ages, and provide data support for subsequent trials.
100 Clinical Results associated with H7N9 Influenza Vaccine (Split Virion),Inactivated(Hualan Biological Bacterin)
100 Translational Medicine associated with H7N9 Influenza Vaccine (Split Virion),Inactivated(Hualan Biological Bacterin)
100 Patents (Medical) associated with H7N9 Influenza Vaccine (Split Virion),Inactivated(Hualan Biological Bacterin)
100 Deals associated with H7N9 Influenza Vaccine (Split Virion),Inactivated(Hualan Biological Bacterin)